Quantum BioPharma Seeks Shareholder Support in $700M Alleged Manipulation Case

Quantum BioPharma Ltd., previously FSD Pharma Inc., has filed a lawsuit in the United States against CIBC World Markets, RBC Dominion Securities, and others. The company claims these entities engaged in market manipulation affecting its share price, leading to substantial financial and emotional losses.

Quantum BioPharma is seeking over $700 million in damages and has assembled prominent legal teams to pursue recovery on a contingency basis, ensuring no upfront legal costs. The company urges shareholders impacted by these actions to join the case, reinforcing its stance against the alleged perpetrators.

Shareholders are encouraged to provide details of their losses to enhance the case. Updated information will be available on the Quantum vs Banks page of their website. The company emphasizes the importance of shareholders coming forward to strengthen the legal proceedings.